Industry funding is matched dollar for dollar by the Ministry of Business, Innovation and Employment.
Pastoral Greenhouse Gas Research Consortium
We are a member of the Pastoral Greenhouse Gas Research Consortium (PGgRc), which is working to reduce greenhouse gas emissions from agriculture. Other members are AgResearch, DairyNZ, DEEResearch, the Fertiliser Manufacturers' Research Association, Fonterra, PGG Wrightson Ltd and Landcorp.
PGgRc was formed and set up by the industry to achieve three goals:
- To identify, establish and develop on-farm technologies to improve production efficiency for ruminants.
- To identify, establish and develop on-farm technologies for sheep, dairy, beef cattle, and deer which lower methane emissions from New Zealand ruminants and nitrous oxide from grazing animal systems.
- To exploit commercial opportunities arising from the science and technologies in a global market.
Since 2002 the consortium has invested around $45 million in scientific programmes aimed at giving farmers the knowledge and tools to mitigate the greenhouse gases produced by grazing animals.
It has produced internationally acknowledged research on the production of methane and nitrous oxide from grazing livestock as part of the most comprehensive programme of its type in the world.
For more information visit the PGgRc website
Pastoral Genomics is a joint venture between B+LNZ, the Foundation for Research, Science and Technology, Fonterra, DairyNZ, DEEResearch and AgResearch.
It uses plant biotechnologies to improve the productivity, sustainability and quality of New Zealand forages.
Pastoral Genomics has developed tools to breed cultivars with smaller environmental footprints, greater productivity and other traits to meet industry targets.
It is working towards cultivars with more dry matter, more metabolisable energy, better digestibility, more efficient fertiliser use, tolerance to drought, greater persistence, and control over traits like flowering.
For more information visit the Pastoral Genomics website
Johne's Disease Research Consortium
We are part of the Johne's Disease Research Consortium, along with DairyNZ, DEEResearch, Livestock Improvement Corporation, Massey University and Otago University.
The science plan focuses on providing tools for farmers and the livestock industries to improve control of Johne's disease across the red meat and dairy sectors.
It takes lessons from overseas into account for more rapid progress.
The plan has four broad areas of investigation:
- Fundamentals: Johne's is a complex disease and there is much more we need to learn about the organism and how the infection behaves.
- Diagnostics: We need to develop New Zealand-specific diagnostic techniques to improve detection of the disease in livestock.
- Genetics: Evidence suggests some animals are more resilient to infection than others. The consortium is looking to genetic solutions for help in breeding animals which are resistant to the disease.
- Herd management: You can use practical management techniques on your farm to minimise the spread of the disease and reduce its impact on your business.
For more information visit the JDRC website
Meat Biologics Research Limited
Beef + Lamb New Zealand is a partner in Meat Biologics Research Limited. The consortium focuses on developing novel nutraceuticals, functional foods and health supplements from red meat or red meat co-products.
These are known as 'meat bioactives'. They are intended for human use, for general health and well-being.
Exploring high growth markets for bioactives from red meat
Research and development targets strategically selected market opportunities that reflect growth areas where New Zealand has a competitive advantage. Each project involves partnering a contracted research provider and a key industry collaborator.
The industry partner takes the lead in manufacturing and marketing all products derived from the project. MBRL has contracted the most pre-eminent bioactive research providers within New Zealand that use cutting edge genomic and proteomic technologies. Consequently, it's making world-leading advances in animal-based bioactives research.
Market segments targeted include bioactives for use against:
- iron deficiency conditions such as anaemia
- angiogenesis – cancerous tumours
- depressed immune systems
To find out more call Consortium Manager Kaylene Larking on 04 494 9503 or email email@example.com